So they lower their PPS target to $40 and the stock drops 20% to $18? Those who got in with the upgrade last week are jumping out, and new traders will come in...I guess.
As a retail trader, you have absolutely no substantive information for the boutique downgrade, and you're the last to know,
I'd like to see this analyst's report, and the reason for the downgrade. It's in the $17's already.
What makes no sense is a 15% drop in pre market on a boutique company's downgrade, after the upgrade last week from the more mainstream analysts.
I don't know what filing they're talking about, there's only the proxy vote filing today, so I'm not sure what I'm missing.
If you're not happy which obviously you're not, then do everyone a favor and sell your shares.
Yeah, that's what they do. They deliberately leverage key conferences with the National Kidney foundation, and share the positive, material efficacy results to time it so they can fund their R&D, for a drug already FDA approved and on the market........Idiot.
Thanks justarook, I assume this is from Twitter; who are you following for this info?
I'm actually surprised to see it's not bid up in AH, but the press release just came out at 6pm est, so it's early, and there's always tomorrow.
Very positive development and presentation,. Thank you for posting.
Julia Skripka-Serry is very very smart, and long RLYP. I've built a very sizable position on the Fibonacci retracement from the April 8th spike high.
Really? It's China's fault and not Apple's fault? Why can't people just embrace that their growth is over and move on?
the official announcement of the buyout cannot be announced because of the quiet period. I have seen acquisitions announced prior to an ER report, but it's rare.
I agree with this ....The businesses are totally unrelated; last I checked AMZN did not rely on an advertising model. Your Algo thesis is spot on.